Inglese

The sample attributes data table includes sample type, body site where sample was extracted, sample analyte type, histological type, and time of tumor sample collection.

6 moduli  
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. The subject consent data table contains subject IDs, consent group information, and affection status for estrogen receptor positive (ER+) breast cancer.
    3. The subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
    4. The subject phenotype data table includes age of enrollment (n=1 variable), tumor pathology (n=10 variables; baseline breast cancer luminal subtype, tumor shape, grade, maximum dimension, number of positive nodes, pathological tumor and node stage, and general comments), PEPI RFS score (n=2 variables), WHO clinical response (n=1 variable) and breast cancer biomarkers (n=15 variables; ER+, Ki-67, and Her2).
    5. The sample attributes data table includes sample type, body site where sample was extracted, sample analyte type, histological type, and time of tumor sample collection.
    6. The pre- and post-subject phenotype data table includes age, sequence of events (n=9 variables; event and recurrence of event, adverse event, follow-up time, survival status, and cause of death), surgical status (n=2 variables), tumor pathology (n=6 variables; baseline tumor type and grade, number of positive nodes, node and tumor stage, and tumor dimension), PEPI RFS score (n=2 variables), and breast cancer biomarkers (n=6 variables; Allred ER+ score and Ki-67).
pht002596
Descrizione

pht002596

Sample ID
Descrizione

SampID

Tipo di dati

string

Alias
UMLS CUI [1,1]
C1299222
Tumor status of the sample
Descrizione

IsTumor

Tipo di dati

string

Alias
UMLS CUI [1,1]
C0475752
Body site from which sample was collected
Descrizione

BodySite

Tipo di dati

string

Alias
UMLS CUI [1,1]
C0449705
Sample nucleic acid type
Descrizione

AnalyteType

Tipo di dati

string

Alias
UMLS CUI [1,1]
C5419066
Type of sample
Descrizione

HistologicalType

Tipo di dati

string

Alias
UMLS CUI [1,1]
C2347029
Time of sample collection (tumor)
Descrizione

Timepoint

Tipo di dati

text

Alias
UMLS CUI [1,1]
C0011008
UMLS CUI [1,2]
C0200345
Ritorna all'inizio della pagina

Similar models

The sample attributes data table includes sample type, body site where sample was extracted, sample analyte type, histological type, and time of tumor sample collection.

6 moduli
  1. StudyEvent: SEV1
    1. Eligibility Criteria
    2. The subject consent data table contains subject IDs, consent group information, and affection status for estrogen receptor positive (ER+) breast cancer.
    3. The subject sample mapping data table includes a mapping of study subject IDs to sample IDs. Samples are the final preps submitted for genotyping, sequencing, and/or expression data. For example, if one patient (subject ID) gave one sample, and that sample was processed differently to generate 2 sequencing runs, there would be two rows, both using the same subject ID, but having 2 unique sample IDs. The data table also includes sample use.
    4. The subject phenotype data table includes age of enrollment (n=1 variable), tumor pathology (n=10 variables; baseline breast cancer luminal subtype, tumor shape, grade, maximum dimension, number of positive nodes, pathological tumor and node stage, and general comments), PEPI RFS score (n=2 variables), WHO clinical response (n=1 variable) and breast cancer biomarkers (n=15 variables; ER+, Ki-67, and Her2).
    5. The sample attributes data table includes sample type, body site where sample was extracted, sample analyte type, histological type, and time of tumor sample collection.
    6. The pre- and post-subject phenotype data table includes age, sequence of events (n=9 variables; event and recurrence of event, adverse event, follow-up time, survival status, and cause of death), surgical status (n=2 variables), tumor pathology (n=6 variables; baseline tumor type and grade, number of positive nodes, node and tumor stage, and tumor dimension), PEPI RFS score (n=2 variables), and breast cancer biomarkers (n=6 variables; Allred ER+ score and Ki-67).
Name
genere
Description | Question | Decode (Coded Value)
Tipo di dati
Alias
Item Group
pht002596
SampID
Item
Sample ID
string
C1299222 (UMLS CUI [1,1])
IsTumor
Item
Tumor status of the sample
string
C0475752 (UMLS CUI [1,1])
BodySite
Item
Body site from which sample was collected
string
C0449705 (UMLS CUI [1,1])
AnalyteType
Item
Sample nucleic acid type
string
C5419066 (UMLS CUI [1,1])
HistologicalType
Item
Type of sample
string
C2347029 (UMLS CUI [1,1])
Item
Time of sample collection (tumor)
text
C0011008 (UMLS CUI [1,1])
C0200345 (UMLS CUI [1,2])
Timepoint
Code List
Time of sample collection (tumor)
CL Item
sample taken at end of treatment (EOT)
CL Item
sample taken at presentation, pre-treatment (baseline)
CL Item
matched normal blood sample (normal)
CL Item
sample taken after 4 months of aromatase-inhibitor therapy (surgery)
Ritorna all'inizio della pagina